The US FDA Approves NuvoAir’s Air Next Spirometer for In-Home Use
Shots:
- The US FDA has granted 510(k) clearance to NuvoAir’s Air Next Spirometer for in-home use as a full spirometer, enabling the expansion of the clinical operations to support patients with heart or lung conditions
- Air Next can provide valuable clinical results to ensure continuous patient monitoring by performing full spirometry at home. These results help the clinical team to identify changes for immediate care before lung function deteriorates to the point of requiring hospitalization
- Additionally, the 510(k) clearance enables the use of the Air Next Spirometer for ATS 2019-compliant spirometry in clinical studies throughout the US and the EU
Ref: Businesswire | Image: NuvoAir
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
